COMPARISON OF EFFICACY OF INFUSIONS OF DEXMEDETOMIDINE VERSUS BUTORPHANOL AS SEDATIVE & ANALGESIC IN SHORT GENERAL ANAESTHESIA IN DAY CARE GYNAECOLOGICAL SURGERIES.
18 Downloads
105 Views
Abstract
Background And Goals: Development of selective alpha 2 adrenoceptor agonists may provide a new concept for the administration of periopertive anaesthesia & analgesia in day care surgeries.Goal of this study was to compare Inj.Dexmedetomidine&Inj.Butorphanol with respect to time required for onset & offset of sedation, quality of intraoperative as well as postoperative analgesia & the time required for post-operative recovery.
Methods: After obtaining permission from Institutional Ethical Committee (IEC), study was conducted in 40 patients of ASA I and || divided into 2 groups A & B by computer generated random number table. Patients, in group A received injDexmedetomidine 1 mcg/kg i.v and group B received inj.Butorphanol 10 mcg/kg i.v, in infusion over 10 minutes prior to induction. Induction was done with injPropofol i.v 2mg/kg & maintained with 33% O2, 66%N2O & 0.6-0.8% of isoflurane with patient breathing spontaneously. Throughout the surgery the sedation and analgesia was maintained with injDexmedetomidine 0.7 microgram/kg/hr infusion in group A and with injButorphanol 2 microgram/kg/hr in group B. Patients were evaluated in postoperative recovery room with help of Visual Analogue Scale (VAS) for pain, Ramsay Sedation Score & Standard Aldrete Score for recovery.
Results: Demographically, the two groups were similar. Requirement of inhalationalanaesthetic agents was significantly reduced in the group A (p < 0.05).VAS was significantly less(2.75 � 0.44) in the group B after 90 min and earlier rescue analgesia was given in group A ( p < 0.05). Eye opening was earlier (45.5 � 23.61) in group A and was highly significant (p < 0.001). Postop recovery was significantly improved (9.8 � 0.41) with dexmeditomidinegroup. Conclusion: Dexmedetomidine produces better sedation and analgesia without significant adverse effects and can be used as sole sedative and analgesic for day care surgery patients with better recovery.
Keywords
Article Analytics
References
- Association for the Study of Pain, Subcommittee on Taxonomy: Classification of chronic pain: Descriptions of chronic pain syndromes and definitions of pain terms. Pain 1986; (suppl 3):S1?225.
- Caruso FS, Pirio AW, Madisso H, Smyth RD, Pachter IJ : Butorphanol, pharmacological and biochemical properties of drug substances. Vol 2. Edited by Goldbrg ME. Washington, American pharmaceutical association, academy of pharmaceutical sciences, 1979, PP 1957.
- Aho M, Erkola O, Kallio A, Scheinin H, Korttila K. Dexmedetomidine infusion for maintenance of anesthesia in patients undergoing abdominal hysterectomy. AnesthAnalg 75:940-6, 1992.
- Naresh RT. Ambulatory Surgery: The Indian Perspective. Cir. May. Amb. 2005; Vol 10 (supl): 19-20.
- Bloor BC, Ward DS, Belleville JP, Maze M. Effects of intravenous dexmedetomidine in II. Hemodynamic changes. Anesthesiology 1992;77:1134‑42.
- Isik B, Arslan M, ?zsoylar O, Ak?abay M. The effects of α2‑adrenergic receptor agonist dexmedetomidine on hemodynamic response in direct laryngoscopy. Open Otorhinolaryngol J 2007;1:5‑
- Gurbet A, Basagan‑Mogol E, Turker G, Ugun F, Kaya FN, Ozcan B. Intraoperative infusion of dexmedetomidine reduces perioperative analgesic requirements. Can J Anaesth2006;53:646‑
- Kallos T and Caruso FS (1979) Respiratory effects of butorphanol and pethidine. Anaesthesia 34:633-637.
- WHO's Certified [Internet]. 34th?ECDD 2006/4.1 Critical review of BUTORPHANOL.???? Available from: http://www.who.int/medicines/areas/quality_safety/4.1ButhorphanolCritReview.pdf [Last cited on 2016 Aug 16].
How to Cite This Article
Anuja Agrawal, Jitender Chauhan and Hetal Parikh. (2017); COMPARISON OF EFFICACY OF INFUSIONS OF DEXMEDETOMIDINE VERSUS BUTORPHANOL AS SEDATIVE & ANALGESIC IN SHORT GENERAL ANAESTHESIA IN DAY CARE GYNAECOLOGICAL SURGERIES., Int. J. of Adv. Res., 5 (02), 2481-2488, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/3430
Corresponding Author
This work is licensed under a Creative Commons Attribution 4.0 International License.





